Valneva Licenses ETEC Vaccine Technology After 30 Years of Research
Updated
Updated · Fox News · Jul 6
Valneva Licenses ETEC Vaccine Technology After 30 Years of Research
1 articles · Updated · Fox News · Jul 6
Summary
Valneva has licensed a new enterotoxigenic E. coli vaccine technology, marking a milestone in a decades-long push to prevent one of the world’s leading causes of severe diarrhea.
The platform targets an ETEC toxin that researchers have long viewed as a major barrier to vaccine development, and outside experts said the proteins appear to trigger strong antibody responses linked to protection.
ETEC causes millions of diarrheal illnesses each year and hits children in low- and middle-income countries especially hard, yet no broadly effective vaccine is currently available.
Clinical use remains years away because the technology is still under development and must undergo further lab work, human trials and regulatory review before any approval.
After decades of failure, what makes this new E. coli vaccine technology different from all the rest?
With declining revenue, can Valneva's bet on this long-shot ETEC vaccine truly revitalize its pipeline?
A French firm now owns a vital vaccine for poor nations. Will profit motives delay its arrival?
Exclusive: Valneva Secures University of Bergen’s ETEC Vaccine Technology to Combat Childhood Diarrhea Worldwide
Overview
In June 2026, Valneva announced an exclusive licensing agreement with the University of Bergen for a novel ETEC vaccine technology, marking a pivotal step in global health. This technology targets a major cause of severe diarrheal disease and is the result of extensive international research led by the University of Bergen and NORCE, with contributions from several global institutions. The agreement highlights Valneva’s commitment to expanding its vaccine portfolio with strategically important candidates, while VIS manages the commercial rights. This collaboration sets the stage for advancing a much-needed solution to a significant global health challenge.